Complete tumor response after concomitant treatment with lenvatinib and radioembolization with Ytrio-90 of advanced stage hepatocarcinoma
Gastroenterol Hepatol. 2024 Jun-Jul;47(6):620-622.
doi: 10.1016/j.gastrohep.2023.09.005.
Epub 2023 Sep 22.
[Article in
English,
Spanish]
Affiliations
- 1 Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, España. Electronic address: [email protected].
- 2 Servicio de Aparato Digestivo, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), Madrid, España.
- 3 Servicio de Radiodiagnóstico, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-IP), Universidad Autónoma de Madrid (UAM), Madrid, España.
No abstract available
MeSH terms
-
Aged
-
Antineoplastic Agents / adverse effects
-
Antineoplastic Agents / therapeutic use
-
Carcinoma, Hepatocellular* / therapy
-
Combined Modality Therapy
-
Embolization, Therapeutic*
-
Humans
-
Liver Neoplasms* / radiotherapy
-
Liver Neoplasms* / secondary
-
Male
-
Middle Aged
-
Neoplasm Staging
-
Phenylurea Compounds* / adverse effects
-
Phenylurea Compounds* / therapeutic use
-
Quinolines* / therapeutic use
-
Radiopharmaceuticals / therapeutic use
-
Remission Induction
-
Yttrium Radioisotopes* / therapeutic use